Matching trials
1,853 results
- Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo: Complete Statistical AnalysisIndependent statistical analysis of Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere’s Disease Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size…
- Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101): Complete Statistical AnalysisIndependent statistical analysis of Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE): Complete Statistical AnalysisIndependent statistical analysis of Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ASSIST-RTIndependent statistical analysis of GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ASTECA detailed statistical analysis and educational interpretation of the ASTEC phase 3 randomized trial of surgery with or without lymphadenectomy and radiation therapy in patients with endometrial cancer.
- ASTRAL-5Independent statistical analysis of Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection: primary endpoint results,…
- ATACIndependent statistical analysis of the ATAC phase 3 clinical trial (NCT00784940), including trial design, endpoints, planned statistical methods, and educational interpretation.
- ATALANTE-1Independent statistical analysis of OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ATHENAComplete statistical analysis of the ATHENA phase 3 trial of dronedarone versus placebo in patients with atrial fibrillation or atrial flutter, including time-to-event endpoints, hazard ratios, confidence intervals, log-rank testing, and statistical…
- ATHENA-1Independent statistical analysis of A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ATLANTISIndependent statistical analysis of the randomized phase 3 ATLANTIS trial evaluating apixaban versus standard of care after trans-aortic valve implantation for aortic stenosis, including trial design, the composite primary endpoint, planned statistical…
- ATNIndependent statistical analysis of Acute Renal Failure Trial Network (ATN) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00076219).
- Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD): Complete Statistical AnalysisIndependent statistical analysis of Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF): Complete Statistical AnalysisIndependent statistical analysis of Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00252967).
- Atralin Gel for the Treatment of Rosacea: Complete Statistical AnalysisIndependent statistical analysis of Atralin Gel for the Treatment of Rosacea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01125930).
- Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A): Complete Statistical AnalysisIndependent statistical analysis of Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ATTACCIndependent statistical analysis of ATTACC (NCT04372589), a randomized phase 2/3 trial evaluating antithrombotic therapy with heparin in patients with COVID-19 and pneumonia, including its design, primary endpoint, planned analysis, and statistical interpretation.
- ATTAIN-1Complete statistical analysis of ATTAIN-1, a randomized phase 3 trial of orforglipron in adults with obesity or overweight with weight-related comorbidities, including its mixed-effects methodology, primary weight endpoint, secondary metabolic outcomes, safety,…
- AtTEndIndependent statistical analysis of the phase 3 AtTEnd trial of atezolizumab in endometrial cancer, covering trial design, progression-free survival, overall survival, planned statistical methods, and interpretation.
- aTTomIndependent statistical analysis of the phase 3 aTTom trial of tamoxifen as adjuvant therapy in women with breast cancer, including trial design, the registered all-cause mortality endpoint, planned statistical analysis, and interpretation.
- ATTRACTIndependent statistical analysis of Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00790335).
- ATTRibute-CMIndependent statistical analysis of Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- AUGMENTIndependent statistical analysis of the phase 3 AUGMENT trial of rituximab plus lenalidomide versus rituximab plus placebo in relapsed or refractory indolent non-Hodgkin's lymphoma, including progression-free survival, overall survival, response endpoints, statistical…
- AURA3Complete statistical analysis of AURA3, the randomized phase 3 trial of osimertinib versus platinum-based doublet chemotherapy in locally advanced or metastatic non-small cell lung cancer, including endpoints, statistical methods, efficacy results, safety,…
- AURIEL-PsOIndependent statistical analysis of MSB11022 in Moderate to Severe Chronic Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02660580).
- AURORAComplete statistical analysis of the phase 3 AURORA trial of cenicriviroc for liver fibrosis in adults with nonalcoholic steatohepatitis, including trial design, registered endpoints, Cochran-Mantel-Haenszel analyses, effect measures, safety, and statistical interpretation.
- Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin’s Lymphoma (BMT CTN 0202): Complete Statistical AnalysisIndependent statistical analysis of Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure: Complete Statistical AnalysisIndependent statistical analysis of Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Avelumab in First-line NSCLC (JAVELIN Lung 100): Complete Statistical AnalysisIndependent statistical analysis of Avelumab in First-line NSCLC (JAVELIN Lung 100): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02576574).
- Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100): Complete Statistical AnalysisIndependent statistical analysis of Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300): Complete Statistical AnalysisIndependent statistical analysis of Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02625623).
- AVERROESIndependent statistical analysis of A Phase III Study of Apixaban in Patients With Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- AVF2107gIndependent statistical analysis of AVF2107g, a randomized phase 3 study evaluating Avastin (bevacizumab) in combination with standard chemotherapy for colorectal cancer.
- AWARD-2Independent statistical analysis of A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01075282).
- AWARD-6Independent statistical analysis of the randomized phase 3 AWARD-6 trial comparing dulaglutide with liraglutide in type 2 diabetes, including the HbA1c non-inferiority analysis, secondary endpoints, statistical methods, safety, and interpretation.
- AWARD-CHN3Independent statistical analysis of A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- AWARD-JPNIndependent statistical analysis of A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- AWARD-PEDSIndependent statistical analysis of A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer: Complete Statistical AnalysisIndependent statistical analysis of Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00920816).
- Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome: primary endpoint…
- AZMATICS: AZithroMycin/Asthma Trial In Community Settings: Complete Statistical AnalysisIndependent statistical analysis of AZMATICS: AZithroMycin/Asthma Trial In Community Settings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00266851).
- AZUREAn independent statistical analysis of AZURE, a randomized phase 3 trial evaluating zoledronic acid with adjuvant or neoadjuvant therapy in women with stage II or stage III breast cancer.
- BALATONIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion: primary endpoint results, effect estimate with confidence…
- BALLAD+Independent statistical analysis of A Phase 3 Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid: primary endpoint results, effect estimate with…
- Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension – CATALYST: Complete Statistical AnalysisIndependent statistical analysis of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- BARIIndependent statistical analysis of the Bypass Angioplasty Revascularization Investigation (BARI), a randomized phase 3 trial comparing percutaneous coronary angioplasty and coronary artery bypass in cardiovascular and coronary disease.
- BARI-COVIDAn independent statistical analysis of the BARI-COVID phase 2/3 study of baricitinib in symptomatic patients infected by COVID-19, including its crossover design, ICU-transfer endpoint, planned analysis, and statistical interpretation.